Replies to post #74 on Nkarta Inc (NKTX)

[jondoeuk]

More (preclinical data) from the same group

[jondoeuk]

Another group plans to test an anti-CD70 CAR-NK (with IL-15) in GBM. Knockout of NR3C1 (steroid receptor pathway) allows for the concurrent use of steroids without negating activity of the therapy